AVANOS MEDICAL, INC PE Ratio 2012-2022 | AVNS

Current and historical p/e ratio for AVANOS MEDICAL, INC (AVNS) from 2012 to 2022. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. AVANOS MEDICAL, INC PE ratio as of August 10, 2022 is 20.90.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

AVANOS MEDICAL, INC PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2022-08-10 28.21 0.00
2022-06-30 27.34 $-0.40 0.00
2022-03-31 33.50 $-0.56 0.00
2021-12-31 34.67 $-1.67 0.00
2021-09-30 31.20 $-1.48 0.00
2021-03-31 43.74 $-0.81 0.00
2020-12-31 45.88 $-0.57 0.00
2020-09-30 33.22 $0.29 114.55
2020-06-30 29.39 $0.67 43.87
2020-03-31 26.93 $0.49 54.96
2019-12-31 33.70 $0.24 140.42
2021-06-30 36.37 $-0.06 0.00
2019-09-30 37.46 $-0.89 0.00
2019-06-30 43.61 $-0.56 0.00
2019-03-31 42.68 $0.34 125.53
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.365B $0.745B
Avanos Medical Inc. operates as a medical technology company. It offers infection prevention, surgical, respiratory, digestive health and pain management solutions. Avanos Medical Inc., formerly known as Halyard Health Inc., is headquartered in Alpharetta, Georgia.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $227.578B 23.18
Edwards Lifesciences (EW) United States $62.887B 44.49
Alcon (ALC) Switzerland $36.987B 31.32
STERIS (STE) Ireland $20.913B 25.96
Teleflex (TFX) United States $11.693B 18.63
Fresenius Medical Care AG KGaA (FMS) Germany $10.936B 10.09
Globus Medical (GMED) United States $6.491B 32.38
Penumbra (PEN) United States $6.042B 724.86
Glaukos (GKOS) United States $2.370B 0.00
Integer Holdings (ITGR) United States $2.345B 18.34
Nevro (NVRO) United States $1.688B 0.00
Paragon 28 (FNA) United States $1.486B 0.00
Artivion (AORT) United States $0.860B 82.00